PRL3 phosphatase active site is required for binding the putative magnesium transporter CNNM3
Abstract The phosphatases of regenerating liver (PRLs) are involved in tumorigenesis and metastatic cancer yet their cellular function remains unclear. Recent reports have shown PRL phosphatases bind tightly to the CNNM family of membrane proteins to regulate magnesium efflux. Here, we characterize...
Guardado en:
Autores principales: | Huizhi Zhang, Guennadi Kozlov, Xinlu Li, Howie Wu, Irina Gulerez, Kalle Gehring |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0fb93675d99f4329802dc664671cbeb7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Erratum: PRL3 phosphatase active site is required for binding the putative magnesium transporter CNNM3
por: Huizhi Zhang, et al.
Publicado: (2017) -
PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
por: Min Thura, et al.
Publicado: (2019) -
Author Correction: PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
por: Min Thura, et al.
Publicado: (2021) -
Crystal structure of an archaeal CorB magnesium transporter
por: Yu Seby Chen, et al.
Publicado: (2021) -
A screen of FDA-approved drugs identifies inhibitors of protein tyrosine phosphatase 4A3 (PTP4A3 or PRL-3)
por: Dylan R. Rivas, et al.
Publicado: (2021)